Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Discovery of origin of oesophageal cancer cells highlights importance of screening for pre-cancerous Barrett’s oesophagus
Abnormal cells that go on develop into oesophageal cancer – cancer that affects the tube…
New therapeutic target discovered for a number of aggressive cancers
A protein in tumour cells could be targeted to treat some types of aggressive cancer…
Truthfulness is key: Critical leadership elements in times of crisis
Truthfulness, acknowledging uncertainty and understanding the workforce are key leadership elements, say senior health leaders. When Professor…
Cancer costs Australia nearly $2 billion per year in lost labour
Antolin Bonnett, The Conversation Australia loses nearly A$2 billion of GDP every year due to people with cancer leaving the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.